SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001561743-19-000039
Filing Date
2019-05-09
Accepted
2019-05-09 16:05:13
Documents
4
Period of Report
2019-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k2019q1earningsrelease.htm 8-K 29735
2 EXHIBIT 99.1 a2019q1earningsrelease.htm EX-99.1 36526
3 capture2a02.jpg GRAPHIC 54266
4 capturea18.jpg GRAPHIC 75767
  Complete submission text file 0001561743-19-000039.txt   246616
Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36225 | Film No.: 19810460
SIC: 2834 Pharmaceutical Preparations